Navigating the complex regulatory environment is a constant challenge in every country. Between evolving standards, stringent documentation requirements, and the need for timely submissions, keeping up can overwhelm even the most efficient teams. Nowhere is this more true than in Brazil, where ensuring compliance with ANVISA (Agência Nacional de Vigilância Sanitária) requires constant attention and
Tag Archives: ANVISA
The pharmaceutical industry in Brazil continues to experience rapid growth, driven by demand for innovative therapies and increasing healthcare access. While that growth presents new opportunities for pharmaceutical companies, navigating the evolving regulatory environment poses significant challenges for companies seeking to bring new products to market. At the heart of the process lies ANVISA (Agência